LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Clinical trials for LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for liver cancer patients after first treatment fails
Disease control Recruiting nowThis study is for people with advanced liver cancer that has spread and cannot be removed by surgery, and whose cancer has continued to grow despite receiving a specific prior immunotherapy combination. It tests whether adding an immunotherapy drug (atezolizumab) to a standard ca…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Could less medicine be enough? study tests lower cancer drug doses
Disease control Recruiting nowThis study is testing a new approach to dosing a cancer immunotherapy drug called atezolizumab. Researchers want to see if they can use blood tests to personalize the timing and amount of the drug, aiming to use lower doses less often while still keeping it effective. The goal is…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Custom cancer vaccine designed to train your own immune system
Disease control Recruiting nowThis study is testing a new, personalized vaccine designed to teach the body's immune system to recognize and attack a patient's specific cancer. It is being given alongside an existing immunotherapy drug (pembrolizumab) to adults with advanced solid tumors that have spread. The …
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New Two-Pronged attack on tough liver cancer
Disease control Recruiting nowThis study is testing if a two-step treatment works better for controlling advanced liver cancer that is still confined to the liver. All patients first receive a targeted radiation treatment directly to the liver tumors. Then, half receive a combination of two immunotherapy drug…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Could a common drug help cancer patients regain lost weight?
Symptom relief Recruiting nowThis study is testing whether olanzapine, a medication that affects brain chemicals, can help cancer patients who are losing too much weight and have poor appetite. The trial will involve 66 adults with advanced cancers of the stomach, liver, pancreas, colon, or lung who have los…
Matched conditions: LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC